Vaxxilon AG is rated 3 out of 5 in the category pharmaceuticals. Read and write reviews about Vaxxilon AG. Vaxxilon AG is focused on the discovery and development of innovative synthetic carbohydrate vaccines. Headquartered near Basel, Switzerland with research labs in Berlin, the Vaxxilon team is advancing several vaccine candidates for the prevention of major infectious diseases.
Address
Christoph Merian-Ring
Company size
11-50 employees
Headquarters
Reinach, Basel-Country